BRAF V600E, the most common mutation in LCH, occurs in 50–60% of cases and leads to continuous MAPK pathway activation, driving uncontrolled Langerhans cell proliferation [2]. This evidence concerns the gene BRAF and Langerhans cell histiocytosis.